Zerodha > Trade @ ₹20 (Free Delivery)Know More
Free Account Opening + AMC Free Demat

Review By Dilip Davda on November 20, 2024

•    The company is engaged in manufacturing and supplying of bio-fuels and its by-products.
•    The company marked quantum jump in its top and bottom lines from FY24 onwards.
•    Based on its FY25 annualized super earnings, the issue appears lucratively priced, while based on FY24 earnings, it is fully priced.
•    Well-informed investors may park moderate fund for medium to long term.

ABOUT COMPANY:
Rajputana Biodiesel Ltd. (RBL) is engaged in the Business of Manufacturing and supplying of bio-fuels and its by-products namely glycerine and fatty acids. It intends to add value to its by-products and explore the export potential of bio-diesel.

RBL's manufacturing unit is operational at G24 RIICO Industrial Area, Phulera, Rajasthan 303338 spread over 4,000 Square Meters. It has an approved production capacity of 30 kilo liters per day (klpd) and an installed production capacity of 24 kilo litre per day (klpd). On the date of this Red Herring Prospectus, its products cover majorly biodiesel, glycerine and fatty acid. The Company has full flexibility in manufacturing facility to handle the multiple feed stocks as per market requirements.

As of July 31, 2024, it had 30 employees on its payroll. 

ISSUE DETAILS/CAPITAL HISTORY:
The company is coming out with its maiden book building route IPO of 1900000 equity shares of Rs. 10 each to mobilize Rs. 24.70 cr. (at the upper cap). The company has announced a price band of Rs. 123* - Rs. 130 per share. The issue opens for subscription on November 26, 2024, and will close on November 28, 2024. The minimum number of shares to be applied is for 1000 shares and in multiples thereon, thereafter. Post allotment, shares will be listed on NSE SME Emerge. The issue constitutes 27.01% of the post-IPO paid-up capital of the company. (Despite a definitive size of the IPO, relevant page of RHP is missing the dilution percentage info). From the net proceeds of the IPO, the company will utilize Rs. 4.20 cr. for loans to its subsidiary Nirvaanraj Energy Pvt. Ltd. for its expansion plans, Rs. 12.20 cr. for working capital, and the rest for general corporate purposes.  (* in a surprised move, the company gave addendum cum corrigendum ad for its price band indicating reduction in the floor price from Rs. 125 to Rs. 123. Does this mean that the allotment will take place at the lower price end???)

The IPO is solely lead managed by GYR Capital Advisors Pvt. Ltd. and Maashitla Securities Pvt. Ltd. is the registrar to the issue. Giriraj Stock Broking Pvt. Ltd. is the Market Maker for the company. GYR Capital Advisors Pvt. Ltd. is the syndicate member for the issue.

Having issued initial equity shares at par value, the company issued further equity shares in the price range of Rs. 15 - Rs. 147 per share between October 2018, and September 2023. It has also issued bonus shares in the ratio of 14 for 1 in March 2023. The average cost of acquisition of shares by the promoters is Rs. 8.61, Rs. 9.02, Rs. 9.08, and Rs. 9.17 per share. 

Post-IPO, company's current paid-up equity capital of Rs. 5.13 cr. will stand enhanced to Rs. 7.03 cr. Based on the upper price band of the IPO, the company is looking for a market cap of Rs. 91.44 cr. 

FINANCIAL PERFORMANCE:
On the financial performance front, for the last three fiscals, the company has (on a consolidated basis) posted a total income/net profit of Rs. 17.46 cr. / Rs. 0.20 cr. (FY22), Rs. 23.54 cr. / Rs. 1.69 cr. (FY23), and Rs. 53.68 cr. / Rs. 4.50 cr. (FY24). For 4M of FY25 ended on July 31, 2024, it earned a net profit of Rs. 3.10 cr. on a total income of Rs. 27.79 cr. The company posted bumper growth in its top and bottom lines from FY24 onwards. The financial data pages of RHP blurred and are not readable properly).

For the last three fiscals, the company has reported an average EPS of Rs. 6.76 and an average RoNW of 27.00%. The issue is priced at a P/BV of 4.24 based on its NAV of Rs. 30.66 as of July 31, 2024, and at P/BV of 2.26 based on its post-IPO NAV of Rs. 57.49 per share (at the upper cap).

If we attribute FY25 annualized super earnings on post-IPO fully diluted equity capital, then the asking price is at a P/E of 9.81, and based on FY24 earnings, the P/E stands at 20.31. The issue appears fully priced. Its borrowings of Rs. 19.89 cr. as of July 31, 2024, raises concern.

For the reported periods, the company has posted PAT margins of 1.17 % (FY22), 7.21 % (FY23), 8.46% (FY24), 9.71% (4M-FY25), and RoCE margins of 11.34%, 22.01%, 22.19%, 11.00% respectively for the referred periods.

DIVIDEND POLICY:
The company has not paid any dividends for the reported periods of the offer document. It will adopt a prudent dividend policy post listing, based on its financial performance and future prospects. 

COMPARISION WITH LISTED PEERS:
As per the offer document, the company has shown Kotyark Ind., as its listed peers. It is trading at a P/E of 34.0 (as of November 19, 2024). However, they are not truly comparable on an apple-to-apple basis. 

MERCHANT BANKER'S TRACK RECORD:
This is the 33rd mandate from GYR Capital in the last four fiscals. Out of last 10 listings, all listed with premiums ranging from 14.07% to 305.44% on the listing date. 


Conclusion / Investment Strategy

The company is engaged in manufacturing and supplying of bio-fuels and its by-products. The company marked quantum jump in its top and bottom lines from FY24 onwards. Its borrowing at Rs. 19.89 cr. as of July 31, 2024, raised concern. On overall financial parameters, the issue appears fully priced. Well-informed investors may park moderate fund for medium to long term.

Review By Dilip Davda on November 20, 2024

Review Author

DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. My reviews do not cover GMP market and operators game plans. Readers must consult a qualified financial advisor before making any actual investment decisions, based the on information published here. With entry barriers, SEBI wants only well-informed investors to participate in such offers. With crazy listings in the recent past, SME IPOs drew the attention of investors across the board and lead to seer madness. However, as SME issues have entry barriers and continued low preference from the broking community, any reader taking decisions based on any information published here does so entirely at their own risk. The above information is based on information available as of date coupled with market perceptions. The Author has no plans to invest in this offer.


About Dilip Davda

Dilip Davda

Dilip Davda is veteran journalist associated with stock market since 1978. He is contributing to print and electronic media on stock markets/insurance/finance since 1985.

Dilip Davda is a leading reviewer of public issues and NCDs in the primary stock market in India. The knowledge he gained over 3 decades while working in the stock market and a strong relationship with popular lead managers makes his reviews unique. His detailed fundamental and financial analysis of companies coming up with IPOs helps investors in the primary stock market. Dilip Davda has a special interest in analyzing the SME companies and writing reviews about their public issues. His reviews are regularly published online and in news papers.

(Dilip Davda -SEBI registered Research Analyst-Mumbai,

Registration no. INH000003127 (Perpetual)

Email id: dilip_davda@rediffmail.com ).

Rajputana Biodiesel IPO FAQs

The initial public offer (IPO) of Rajputana Biodiesel Ltd. offers an early investment opportunity in Rajputana Biodiesel Ltd.. A stock market investor can buy Rajputana Biodiesel IPO shares by applying in IPO before Rajputana Biodiesel Ltd. shares get listed at the stock exchanges. An investor could invest in Rajputana Biodiesel IPO for short term listing gain or a long term.

Read the Rajputana Biodiesel IPO recommendations by the leading analyst and leading stock brokers.

Rajputana Biodiesel IPO offers an opportunity to buy IPO shares before they get listed at the stock exchanges. Read the Rajputana Biodiesel IPO Notes, Analysis and Recommendations by leading stock brokerage firms and experts mentioned in the above answer to "How is Rajputana Biodiesel IPO?"

Our recommendation for Rajputana Biodiesel IPO is to subscribe for long term.

As per the analysis by our lead analyst Mr. Dilip Davda, we suggest you to subscribe for long term to the Rajputana Biodiesel IPO.

The Rajputana Biodiesel IPO allotment status will be available on or around November 29, 2024. The allotted shares will be credited in demat account by December 2, 2024. Visit Rajputana Biodiesel IPO allotment status to check.

The Rajputana Biodiesel IPO will list on Tuesday, December 3, 2024.